First systemic CTCL therapy approved in more than seven years LYMPHIR delivers targeted therapy for a rare and incurable form of skin lymphoma while opening doors for broader immuno-oncology applications.

https://www.drugdiscoverynews.com/first-systemic-ctcl-therapy-approved-in-more-than-seven-years-16920